Effect of Nimbadi yonivarti and Vidangadi lauha in vaginal discharge

A randomized clinical trial of swetapradara w.s.r. to infective vaginal discharge with Nimbadi yonivarti and Vidangadi lauha

Status

Active, not recruiting

Phases

Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2016/02/006606

Enrollment

300

Registered

2016-02-03

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N00-N99- Diseases of the genitourinary system Health Condition 2: null- Patients who suffering from infective vaginal discharge

Interventions

Intervention1: Group A:Nimbadi Yonivarti: Group A:Nimbadi Yonivarti of 3 gm once a day at bed time Intervention2: Group A:Nimbadi Yonivarti: 1 Vaginal suppository(Nimbadi Yonivarti) of 3gm once a da

Eligibility

Inclusion criteria

Inclusion criteria: Married women. The patients having clinical signs and symptoms of Swetapradara i.e. features of white discharge with itching / any abnormal smell/swelling ,redness. Detection of pathogen by wet vaginal smear examination including any featrures either one/ two/three/all. Hemoglobin greater than 7gms%

Exclusion criteria

Exclusion criteria: Unmarried women Age below 20 years and above 50 years pregnant women patients suffering from tuberculosis, HIV, VDRL, Genital malignancy and Congenital and any other organic pathologies of reproductive tract Hemoglobin less than 7

Design outcomes

Primary

Measure	Time frame
To evaluate and compare the effect of Nimbadi Yonivarti and Nimbadi Yonivarti with Vidangadi lauha orally in the management of Swetapradara w.s.r. infective vaginal dischargeTimepoint: 16 days	—

Secondary

Measure	Time frame
To prevent recurrence rate of infective vaginal dischargeTimepoint: 45 days	—

Countries

India

Contacts

Public ContactProf L P dei

Institute for Post Graduate Teaching and Research in Ayurveda

deikaxmipriya@yahoo.com9228198366

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026